The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: An alternative trans-diagnostic model

CNS Spectrums

Volumn 21, Issue 4, 2016, Pages 310-317

  Cosci, Fiammetta ^a   Fava, Giovanni A ^b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Clinimetric; Diagnostic Criteria for Psychosomatic Research; DSM 5; illness behavior; somatic symptom

Indexed keywords

ALEXITHYMIA; ANXIETY DISORDER; BODY DYSMORPHIC DISORDER; CLINICAL CLASSIFICATION; DSM-5; FACTITIOUS DISEASE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPOCHONDRIASIS; ILLNESS BEHAVIOR; MENTAL DISEASE; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; RESEARCH DIAGNOSTIC CRITERIA; REVIEW; CLASSIFICATION; CONVERSION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MEDICALLY UNEXPLAINED SYMPTOM; SOMATOFORM DISORDER;

CONVERSION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTITIOUS DISORDERS; HUMANS; HYPOCHONDRIASIS; ILLNESS BEHAVIOR; MEDICALLY UNEXPLAINED SYMPTOMS; SOMATOFORM DISORDERS;

EID: 84952000314     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852915000760     Document Type: Review

References (71)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Sirri L, Fava GA. Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry. 2013; 25(1): 19-30.
3. van den Heuvel OA, Veale D, Stein DJ. Hypochondriasis: considerations for ICD-11. Rev Bras Psiquiatr. 2014; 36(Suppl 1): 21-27.
4. Calkins AW, Berman NC, Wilhelm S. Recent advances in research on cognition and emotion in OCD: a review. Curr Psychiatry Rep. 2013; 15(5): 357.
5. Veale D, Gournay K, Dryden W, et al. Body dysmorphic disorder: a cognitive behavioural model and a pilot randomised controlled trial. Behav Res Ther. 1996; 34(9): 717-729.
6. Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013; 82(1): 20-34.
7. Stone J, Carson A, Duncan R, et al. Symptoms "unexplained by organic disease" in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009; 132(Pt 10): 2878-2888.
8. Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom. 2015; 84(1): 22-29.
9. Sirri L, Fava GA. Clinical manifestations of hypochondriasis and related conditions. In: Starcevic V, Noyes R, eds. Hypochondriasis and Health Anxiety. A Guide for Clinicians. Oxford, UK: Oxford University Press; 2014: 8-27.
10. Lipowski ZJ. Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom. 1987; 47(3-4): 160-167.
11. Härter M, Baumeister H, Reuter K, et al. Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom. 2007; 76(6): 354-360.
12. Engel GL. Psychological aspects of gastrointestinal disorders. In: Reiser MF, ed. American Handbook of Psychiatry. New York: Basic Books; 1975: 653-692.
13. Fava GA, Sonino N. The clinical domains of psychosomatic medicine. J Clin Psychiatry. 2005; 66(7): 849-858.
14. Ly HG, Ceccarini J, Weltens N, et al. Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study. Psychother Psychosom. 2015; 84(3): 149-158.
15. Pilowsky I. Abnormal Illness Behaviour. Chichester, England:Wiley; 1997.
16. Mechanic D, Volkart EH. Illness behavior and medical diagnoses. J Health Hum Behav. 1960; 1(2): 86-94.
17. Mechanic D. Sociological dimensions of illness behavior. Soc Sci Med. 1995; 41(9): 1207-1216.
18. Sirri L, Fava GA, Sonino N. The unifying concept of illness behavior. Psychother Psychosom. 2013; 82(2): 74-81.
19. Fava GA, Kellner R, Zielezny M, et al. Hypochondriacal fears and beliefs in agoraphobia. J Affect Disord. 1988; 14(3): 239-244.
20. Fava GA, Porcelli P, Rafanelli C, et al. The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry. 2010; 71(7): 910-914.
21. Sonino N, Sirri L, Fava GA. Including illness behavior in the assessment of endocrine patients. J Clin Endocrinol Metab. 2014; 99(9): 3122-3124.
22. Fava GA, Freyberger HJ, Bech P, et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom. 1995; 63(1): 1-8.
23. Hanel G, Henningsen P, Herzog W, et al. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res. 2009; 67(3): 189-197.
24. Leiknes KA, Finset A, Moum T, et al. Overlap, comorbidity, and stability of somatoform disorders and the use of current versus lifetime criteria. Psychosomatics. 2008; 49(2): 152-162.
25. Porcelli P, Guidi J. The clinical utility of the Diagnostic Criteria for Psychosomatic Research (DCPR): a review of studies. Psychother Psychosom. 2015; 84(5): 265-272.
26. Porcelli P, Sonino N. Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Advances in Psychosomatic Medicine. Basel, Switzerland: Karger; 2007.
27. Tomba E, Rafanelli C, Grandi S, et al. Clinical configuration of cyclothymic disturbances. J Affect Disord. 2012; 139(3): 244-249.
28. Galeazzi GM, Ferrari S, Mackinnon A, et al. Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients. Psychosomatics. 2004; 45(5): 386-393.
29. Fava GA, Guidi J, Porcelli P, et al. A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychol Med. 2012e; 42(2): 401-407.
30. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press; 1987.
31. Fava GA, Tomba E, Sonino N. Clinimetrics: the science of clinical measurements. Int J Clin Pract. 2012; 66(1): 11-15.
32. Fava GA, Sonino N, Wise TN. The Psychosomatic Assessment. Strategies to Improve Clinical Practice. Advances in Psychosomatic Medicine. Basel, Switzerland: Karger; 2012.
33. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970; 23(7): 455-468.
34. Feinstein AR. An analysis of diagnostic reasoning. I. The domains and disorders of clinical microbiology. Yale J Biol Med. 1973; 46(3): 212-232.
35. Avia MD, Ruiz MA, Olivares ME, et al. The meaning of psychological symptoms. Behav Res Ther. 1996; 34(1): 23-31.
36. Warwick HM, Clark DM, Cobb AM, et al. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996; 169(2): 189-195.
37. Bouman TK, Visser S. Cognitive and behavioural treatment of hypochondriasis. Psychother Psychosom. 1998; 67(4-5): 214-221.
38. Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis. Br J Psychiatry. 1998; 173(3): 218-225.
39. Fava GA, Grandi S, Rafanelli C, et al. Explanatory therapy of hypochondriasis. J Clin Psychiatry. 2000; 61(4): 317-322.
40. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004; 291(12): 1464-1470.
41. Nakao M, Shinozaki Y, Ahern DK, et al. Anxiety as a predictor of improvements in somatic symptoms and health anxiety associated with cognitive-behavioral intervention in hypochondriasis. Psychother Psychosom. 2011; 80(3): 151-158.
42. Tyrer P, Salkovskis P, Tyrer H, et al. Cognitive behaviour therapy for health anxiety. Lancet. 2014; 383(9925): 1295-1296.
43. Porcelli P, Bellomo A, Quartesan R, et al. Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother. Psychosom. 2009; 78(6): 352-358.
44. Fava GA, Grandi S. Differential diagnosis of hypochondriacal fears and beliefs. Psychother Psychosom. 1991; 55(2-4): 114-119.
45. Noyes R, Carney CP, Langbehn DR. Specific phobia of illness: search for a new subtype. J Anxiety Disord. 2004; 18(4): 531-545.
46. Sonino N, Navarrini C, Ruini C, et al. Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom. 2004; 73(2): 78-83.
47. Porcelli P, De Carne M, Fava GA. Assessing somatization in functional gastrointestinal disorders: integration of different criteria. Psychother Psychosom. 2000; 69(4): 198-204.
48. Engel GL. Conversion symptoms. In: MacBryde CM, Blacklow RS, eds. Signs and Symptoms, Applied Pathological Physiology and Clinical Interpretation. Philadelphia: Lippincott; 1970: 650-668.
49. Porcelli P, Fava GA, Rafanelli C, et al. Anniversary reactions in medical patients. J Nerv Ment Dis. 2012; 200(7): 603-606.
50. Goldbeck R. Denial in physical illness. J Psychosom Res. 1997; 43(6): 575-593.
51. Grassi L, Sabato S, Rossi E, et al. Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom. 2005; 74(2): 100-107.
52. Grandi S, Sirri L, Tossani E, et al. Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry. 2011; 72(5): 648-654.
53. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N. Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom. 2010; 79(5): 280-284.
54. Frank JD. Persuasion and Healing. Baltimore, MD: Johns Hopkins University Press; 1961.
55. Schmale AH, Engel GL. The giving up-given up complex illustrated on film. Arch Gen Psychiatry. 1967; 17(2): 133-145.
56. Tecuta L, Tomba E, Grandi S, et al. Demoralization: a systematic review on its clinical characterization. Psychol Med. 2015; 45(4): 673-691.
57. Snaith RP, Taylor CM. Irritability: definition, assessment and associated factors. Br J Psychiatry. 1985; 147(2): 127-136.
58. Rafanelli C, Sirri L, Grandi S, et al. Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom. 2013; 82(5): 285-291.
59. Friedman M, Rosenman RH. Type A Behavior and Your Heart. New York: Knopf; 1974.
60. Sirri L, Fava GA, Guidi J, et al. Type A behaviour: a reappraisal of its characteristics in cardiovascular disease. Int J Clin Pract. 2012; 66(9): 854-861.
61. Sifneos PE. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom. 1973; 22(2): 255-262.
62. Taylor GJ. Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom. 2010; 79(6): 339-349.
63. De Vries AM, Forni V, Voellinger R, et al. Alexithymia in cancer patients: review of the literature. Psychother Psychosom. 2012; 81(2): 79-86.
64. Lumley MA, Neely LC, Burger AJ. The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess. 2007; 89(3): 230-246.
65. Porcelli P, Bagby RM, Taylor GJ, et al. Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med. 2003; 65(5): 911-918.
66. Honkalampi K, Lehto SM, Koivumaa-Honkanen H, et al. Alexithymia and tissue inflammation. Psychother Psychosom. 2011; 80(6): 359-364.
67. Cosci F. Assessment of personality in psychosomatic medicine: current concepts. Adv Psychosom Med. 2012; 32: 133-159.
68. Guidi J, Rafanelli C, Roncuzzi R, et al. Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry. 2013; 35(2): 141-146.
69. Engel GL. A unified concept of health and disease. Perspect Biol Med. 1960; 3: 459-485.
70. Evers AW, Gieler U, Hasenbring MI, van Middendorp H. Incorporating biopsychosocial characteristics into personalized healthcare. Psychother Psychosom. 2014; 83(3): 148-157.
71. Fava GA, Guidi J, Rafanelli C, Sonino N. The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom. 2015; 84(1): 1-3.